- Home
- ISPO vs BNR Comparison
ISPO vs BNR Comparison
Compare ISPO & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPO
- BNR
- Stock Information
- Founded
- ISPO 2010
- BNR 2014
- Country
- ISPO United States
- BNR China
- Employees
- ISPO N/A
- BNR N/A
- Industry
- ISPO Blank Checks
- BNR Medical Specialities
- Sector
- ISPO Finance
- BNR Health Care
- Exchange
- ISPO Nasdaq
- BNR Nasdaq
- Market Cap
- ISPO 44.3M
- BNR 38.3M
- IPO Year
- ISPO N/A
- BNR 2020
- Fundamental
- Price
- ISPO $3.03
- BNR $6.90
- Analyst Decision
- ISPO
- BNR
- Analyst Count
- ISPO 0
- BNR 0
- Target Price
- ISPO N/A
- BNR N/A
- AVG Volume (30 Days)
- ISPO 47.0K
- BNR 57.4K
- Earning Date
- ISPO 08-12-2025
- BNR 08-21-2025
- Dividend Yield
- ISPO N/A
- BNR N/A
- EPS Growth
- ISPO N/A
- BNR N/A
- EPS
- ISPO N/A
- BNR N/A
- Revenue
- ISPO $265,499,000.00
- BNR $72,112,038.00
- Revenue This Year
- ISPO N/A
- BNR $136.32
- Revenue Next Year
- ISPO $148.67
- BNR N/A
- P/E Ratio
- ISPO N/A
- BNR N/A
- Revenue Growth
- ISPO N/A
- BNR 0.53
- 52 Week Low
- ISPO $2.19
- BNR $2.18
- 52 Week High
- ISPO $7.17
- BNR $9.48
- Technical
- Relative Strength Index (RSI)
- ISPO 49.71
- BNR 58.58
- Support Level
- ISPO $2.45
- BNR $6.03
- Resistance Level
- ISPO $3.23
- BNR $7.80
- Average True Range (ATR)
- ISPO 0.26
- BNR 1.00
- MACD
- ISPO 0.06
- BNR -0.08
- Stochastic Oscillator
- ISPO 79.25
- BNR 32.51
About ISPO Inspirato Incorporated
Inspirato Inc is a private, luxury hospitality club that provides its members with access to an exclusive portfolio of high-end vacation homes, luxury hotels, and curated travel experiences worldwide. The club offers personalized service, dedicated trip planning, and seamless access to exceptional properties through its innovative model designed to ensure the service, certainty and value that discerning customers demand. The Inspirato portfolio of curated luxury vacation options includes approximately 350 private luxury vacation homes and accommodations at over 220 luxury hotel and resort partners in over 180 destinations around the world.
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.